XML 34 R24.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Revenue (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Revenue From Contract With Customer [Abstract] |
Schedule of Disaggregated Revenue | The following table presents our disaggregated revenue for the periods presented (in thousands):
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Immune Medicine revenue |  |  |  |  |  |  |  |  |  |  |  |
Service revenue |  | $ | 6,559 |  |  | $ | 8,169 |  |  | $ | 20,968 |  |  | $ | 17,622 |
Collaboration revenue |  |  | 21,320 |  |  |  | 15,446 |  |  |  | 50,105 |  |  |  | 49,137 |
Total Immune Medicine revenue |  |  | 27,879 |  |  |  | 23,615 |  |  |  | 71,073 |  |  |  | 66,759 |
MRD revenue |  |  |  |  |  |  |  |  |  |  |  |
Service revenue |  |  | 19,951 |  |  |  | 14,352 |  |  |  | 55,037 |  |  |  | 39,655 |
Regulatory milestone revenue |  |  | — |  |  |  | 1,500 |  |  |  | 4,000 |  |  |  | 10,000 |
Total MRD revenue |  |  | 19,951 |  |  |  | 15,852 |  |  |  | 59,037 |  |  |  | 49,655 |
Total revenue |  | $ | 47,830 |  |  | $ | 39,467 |  |  | $ | 130,110 |  |  | $ | 116,414 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration